Cryotherapy Market to Augment at an Impressive CAGR of 11.2% from 2023 to 2033 Owing to the Increasing Number of Non-Invasive and Minimally Invasive Procedures | Future Market Insights, Inc.
Future Market Insights Global and Consulting Pvt. Ltd.
7 min read
Future Market Insights Global and Consulting Pvt. Ltd.
USA Cryotherapy Market is expected to have the highest market of US$ 4.5 Billion by the end of 2033. The Cryotherapy in the United Kingdom is expected to reach a valuation of US$ 653 Million by 2033, growing at a CAGR of 10.9% from 2023 to 2033
DUBAI, United Arab Emirates, March 19, 2023 (GLOBE NEWSWIRE) -- The global Cryotherapy Market is anticipated to create an absolute dollar opportunity over the forecast period by exhibiting a CAGR of 11.2% from 2023 to 2033. The global market held a valuation of US$ 4.4 Billion in 2022 and the projected market growth from 2023 to 2033 is expected to be significantly higher than the historical growth. Surgical applications are expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 11.6% over the evaluation period. According to the historical analysis conducted by Future Market Insights, the global cryotherapy market registered a CAGR of 9.3% from 2018 to 2022.
Cryotherapy is known as a non-invasive therapy used for treating abnormal skin, alleviating pain, and localized tumors. It is a commonly used term in medical sciences to describe the use of cold temperatures to cure cancerous tissues and lesions caused by cancer. Muscle soreness, sprains, edema, soft tissue damage, and postoperative swelling are all prominent uses for cryotherapy.
The increasing number of non-invasive and minimally invasive procedures performed each year is the optimal driver of the worldwide cryotherapy market. Because of the expanding consumer preference for enhancing one's physical characteristics and addressing skin disorders, the demand for non-invasive and minimally invasive procedures is increasing tremendously. Furthermore, the introduction of thin and efficient probes in a variety of sizes, the use of supercooled nitrogen or other cryogens for chilling, and the use of narrow cryoablation needles are only a few instances of cryosurgical equipment advancements.
Cryotherapy is mostly used in the medical treatment of a variety of skin diseases, as we as the treatment of some prostate cancers and dysplastic cervix tissue. Cryosurgery has the advantage of healing faulty tissues without damaging the body's damaged tissues. Dermatology, cancer, cardiology, ophthalmology, and gynecology are among the illnesses for which cryotherapy is used.
The global cryotherapy industry is fuelled by technological improvements in cryotherapy equipment. Because of developments in cryotherapy and several technical innovations, cryotherapy has become an important treatment option. Different types of equipment, such as cryosurgery machines and accessories, have undergone many changes.
Increasing product introductions, low-cost cryotherapy devices, and rising cryotherapy device use are also projected to drive market growth throughout the forecast period. Adding to it, key market players are focused on collaborations leading to innovations and ultimately leading to market growth.
Recent Developments
Owing to the rising technological developments and a growing focus on broadening cryotherapy applications, surging investment in the healthcare sector by developing countries, and unexplored potential in new markets all point to favorable growth prospects. Cryotherapy is also being investigated for uses in the treatment of a variety of other medical ailments and diseases as one of the most promising options because it is less intrusive and drug-free.
Some obstacles and constraints are likely to impede the total market expansion. A shortage of skilled workers such as medical professionals, nurses, and doctors, would be one of these issues. Additionally, modest growth is expected during the predicted period because of the restricted availability of cryotherapy and a lack of awareness. The potentially harmful effects of cryogenic gases, as well as tight product approval laws, are possible restraints on the worldwide cryotherapy market's overall growth.
Cryotherapy is also becoming more popular as the incidence of cancer, sports injuries, and cardiac disorders rise. Furthermore, the rising application of this method for cosmetic treatments in dermatology is expected to drive the worldwide cryotherapy market's growth.
Some of the key players in the market include AstraZeneca Plc, Addgene, Caribou Biosciences, Boston Scientific Corporation, Brymill Cryogenic Solutions, Stryker, and Cryoalfa.
In June 2022, Erbe Elektromedizin GmbH, Erbe USA, Incorporated's parent business announced plans to buy Maxer Endoscopy GmbH. The strategic acquisition of the German fluorescence-guided surgery pioneer will boost Erbe's surgical endoscopy business. As a result of this transaction, Erbe Elektromedizin's operating room presence will be strengthened.
More Insights into the Cryotherapy Market
The North American region is anticipated to dominate the global cryotherapy market over the assessment period. The U.S.A. is expected to have the highest market of US$ 4.5 Billion by the end of 2033. The region's large share is due to its well-established healthcare infrastructure, advantageous reimbursement conditions, and widespread use of technologically advanced solutions.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain
Lateral Flow Assays Market Share: The lateral flow assay market size is projected to be valued at US$ 4.3 billion in 2023 and is expected to rise to US$ 6.9 billion by 2033. The sales of lateral flow assay are expected to register a CAGR of 4.7% during the forecast period.
Surgical Instruments Tracking System Market Growth: The global surgical instrument tracking system market is estimated to reach a valuation of US$ 255 billion in 2023. As per Future Market Insights (FMI) analysis, the surgical instrument tracking system market size is expected to surpass S$ 940 billion in the next decade. Between 2023 and 2033, the market has been forecast to register a 13.9% CAGR.
Endometrial Ablation Market Demand: The Endometrial Ablation Market was valued at US$ 3.2 Billion in 2022 and is expected to grow with a CAGR of 7.3% from 2023 to 2033.
Pleural Diseases Therapeutics Market Size: Expected to be valued at US$ 4.98 billion in 2023, the market for pleural diseases therapeutics is estimated to register a compounded annual growth rate (CAGR) of 6.5% from 2023 to 2033. According to Future Market Insights, the market is expected to reach US$ 9.4 billion by the end of the said forecast period.
Optic Atrophy Management Market Opportunity: The global optic atrophy management market is expected to reach a valuation of US$ 8 billion in 2023 and is projected to exhibit a CAGR of 4.9% from 2023 to 2033. By the end of the aforementioned forecast period, the market is likely to close at US$ 15.63 billion.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
